-

BioCentury Grand Rounds U.S. Returns to Seattle in June to Break Down Translational Bottlenecks Between Innovation and Investment

Bridging Academic Research and Drug Development: Registration Now Open for the Premier Forum at the Academic/Industry Interface

SEATTLE--(BUSINESS WIRE)--BioCentury Grand Rounds U.S., taking place June 3-5 in Seattle, Washington, is a premier gathering for leaders at the intersection of emerging science and drug development, convening VCs, biopharma executives, academic innovators and biotech founders for the kind of cross-sector dialogue that rarely happens elsewhere. BioCentury is now accepting registrations, poster presentation applications and Presenting Company nominations.

The core value of Grand Rounds U.S. lies in the community it brings together and the direct, meaningful interactions it fosters.

Share

Grand Rounds U.S. is an intentionally intimate forum built around science as the translational frontier that promotes genuine connections and network expansion. Our regional host committee currently includes Allen Institute, CoMotion, Fred Hutchinson Cancer Center and Life Science Washington, with investment banking sponsor J. P. Morgan and supporting organizations AUTM and Chicago Biomedical Consortium. Speaker highlights include Nobel Laureates David Baker and Mary Brunkow. Explore our full list of sponsors, speakers, panel discussion topics and more on our conference site.

The core value of Grand Rounds U.S. lies in the community it brings together and the direct, meaningful interactions it fosters. It’s where rigorous debate is welcome, partnering is intentional and translational science is given the platform it deserves so attendees can forge a clear path from academia to industry. Learn more about Grand Rounds U.S., apply to present and take advantage of Presenting Company benefits or submit your poster abstract and attend with our special academic pass.

For more information on BioCentury Grand Rounds U.S. and to register, visit www.BioCenturyGrandRoundsUS.com or contact conferences@biocentury.com.

ABOUT BIOCENTURY

BioCentury is a research-driven knowledge company helping biopharma executives and investors make business-critical decisions for more than 30 years. Through deep analysis, trusted reporting, and global convenings, BioCentury connects leaders across the innovation ecosystem to drive the translation of science into solutions.

Contacts

BioCentury, Inc.
Michael Kelly | Senior Marketing Manager, Event Growth & Demand Strategy
conferences@biocentury.com

BioCentury, Inc.


Release Summary
BioCentury Grand Rounds U.S. returns to Seattle June 3-5, bridging translational science research and drug development. Registration now open.
Release Versions

Contacts

BioCentury, Inc.
Michael Kelly | Senior Marketing Manager, Event Growth & Demand Strategy
conferences@biocentury.com

More News From BioCentury, Inc.

The 6th BioCentury-BayHelix East-West Biopharma Summit Returns to Seoul Amid Unprecedented Demand for Cross-Border Deals

SEOUL, South Korea--(BUSINESS WIRE)--BioCentury today announced that the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) will serve as Regional Host Chair of the 6th BioCentury-BayHelix East-West Biopharma Summit, taking place March 15-17, 2027, at the Conrad Seoul in South Korea. Presented by BioCentury, BayHelix, and Insights Partner McKinsey & Company, the East-West Biopharma Summit returns to Seoul for the second time to continue the debate on Asia’s Arc of Innovati...

BioCentury Grand Rounds Heads to Houston, Texas, for Its Sixth Meeting Designed to Connect Early-Stage Science with Today’s Investors and Executives

HOUSTON--(BUSINESS WIRE)--BioCentury is pleased to announce that registration is now open for the sixth edition of BioCentury Grand Rounds, taking place April 12–14, 2027, in Houston, Texas. The conference convenes academic innovators, biotech founders, biopharma leaders, and investors to bridge the gap between early-stage science and breakthrough new medicines. Registration, scientific poster nominations, and Presenting Company applications are now open. “Houston is a leading center for medici...

BioCentury to Host Grand Rounds in Chicago: Where Translational Science Meets Investors and Dealmakers

CHICAGO--(BUSINESS WIRE)--Top decision-makers from across the biopharma ecosystem will convene in Chicago for the 2nd BioCentury Grand Rounds – U.S., at the intersection of research, investment and drug development. Designed to drive practical progress in R&D, the conference connects academic innovators with biopharma executives and early-stage investors who are building the next wave of biotech breakthroughs. Taking place June 4 – 6 at the Four Seasons Hotel Chicago, the program will addre...
Back to Newsroom